MHC class II molecules display antigenic peptides on cell surfaces for recognition by CD4(+) T cells. Proteolysis is required in this process both for degradation of invariant chain (Ii) from class II-Ii complexes to allow subsequent binding of peptides, and for generation of the antigenic peptides. The cysteine endoprotease, cathepsin S, mediates Ii degradation in human and mouse antigen-presenting cells. Studies described here examine the functional significance of cathepsin S inhibition on antigen presentation and immunity. Specific inhibition of cathepsin S in A20 cells markedly impaired presentation of an ovalbumin epitope by interfering with class II-peptide binding, not by obstructing generation of the antigen. Administration of a cathepsin S inhibitor to mice in vivo selectively inhibited activity of cathepsin S in splenocytes, resulting in accumulation of a class II-associated Ii breakdown product, attenuation of class II-peptide complex formation, and inhibition of antigen presentation. Mice treated with inhibitor had an attenuated antibody response when immunized with ovalbumin but not the T cell-independent antigen TNP-Ficoll. In a mouse model of pulmonary hypersensitivity, treatment with the inhibitor also abrogated a rise in IgE titers and profoundly blocked eosinophilic infiltration in the lung. Thus, inhibition of cathepsin S in vivo alters Ii processing, antigen presentation, and immunity. These data identify selective inhibition of cysteine proteases as a potential therapeutic strategy for asthma and autoimmune disease processes.
R J Riese, R N Mitchell, J A Villadangos, G P Shi, J T Palmer, E R Karp, G T De Sanctis, H L Ploegh, H A Chapman
Title and authors | Publication | Year |
---|---|---|
The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity
A Sá-Nunes, A Bafica, LR Antonelli, EY Choi, IM Francischetti, JF Andersen, GP Shi, T Chavakis, JM Ribeiro, M Kotsyfakis |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Cathepsin K inhibitors for osteoporosis and potential off-target effects
D Brömme, F Lecaille |
Expert Opinion on Investigational Drugs | 2009 |
Expression of survivin in lung eosinophils is associated with pathology in a mouse model of allergic asthma
DJ Tumes, A Connolly, LA Dent |
International Immunology | 2009 |
Matrix Degrading Proteinases in COPD and Asthma
SD Shapiro |
Asthma and COPD | 2009 |
Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice
L Svelander, H Erlandsson-Harris, L Astner, U Grabowska, L Klareskog, E Lindstrom, E Hewitt |
European Journal of Pharmacology | 2009 |
Synaptic Plasticity in Pain
M Malcangio |
2009 | |
Cathepsin S Regulates Class II MHC Processing in Human CD4 + HLA-DR + T Cells
CM Costantino, HL Ploegh, DA Hafler |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Grassystatins A−C from Marine Cyanobacteria, Potent Cathepsin E Inhibitors That Reduce Antigen Presentation
JC Kwan, EA Eksioglu, C Liu, VJ Paul, H Luesch |
Journal of Medicinal Chemistry | 2009 |